A clinically feasible protocol of TCR gene editing to treat Multiple Myeloma without inducing GvHD

被引：0

作者：

Mastaglio, S. ^{[1
]}

Genovese, P. ^{[1
]}

Magnani, Z. ^{[1
]}

Camisa, B. ^{[1
]}

Landoni, E. ^{[1
]}

Schiroli, G. ^{[1
]}

Provasi, E. ^{[1
]}

Lombardo, A. ^{[1
]}

Reik, A. ^{[2
]}

Cieri, N. ^{[1
]}

Ponzoni, M. ^{[1
]}

Ciceri, F. ^{[1
]}

Bordignon, C. ^{[3
]}

Holmes, M. ^{[2
]}

Gregory, P. ^{[2
]}

Naldini, L. ^{[1
]}

Bonni, C. ^{[1
]}

机构：

[1] Ist Sci San Raffaele, I-20132 Milan, Italy

[2] Sangamo Biosci, Richmond, CA USA

[3] Molmed, Milan, Italy

来源：

BONE MARROW TRANSPLANTATION | 2015年 / 50卷

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P050

引用

页码：S143 / S143

页数：1

共 50 条

[21] TCR Gene Editing Achieved In a Single Round Of T Cell Activation Is Sufficient To Redirect T Cell Specificity and Prevent GvHD
Mastaglio, Sara
Genovese, Pietro
Magnani, Zulma
Provasi, Elena
Lombardo, Angelo
Reik, Andreas
Cieri, Nicoletta
Ciceri, Fabio
Bordignon, Claudio
Holmes, Michael C.
Gregory, Philip D.
Naldini, Luigi
Bonini, Chiara
BLOOD, 2013, 122 (21)
[22] Efficacy and safety of plasmapheresis without plasma transfusion tandem with chemotherapy to treat multiple myeloma
Guo, Yigang
Zhang, Lulu
Zhang, Rongyao
Zhou, Meiling
Chen, Xu
Wan, Chucheng
Hu, Ping
He, Yuanyuan
Jiang, Hua
Geng, Wei
Zhang, Weixing
Kanwal, Fariha
Rehman, Muhammad Fayyaz Ur
Li, Zhangzhi
HEMATOLOGY, 2022, 27 (01) : 1217 - 1222
[23] Therapeutic status and the prospect of CRISPR/Cas9 gene editing in multiple myeloma
Hong, Lemin
Zhang, Chenlu
Jiang, Yijing
Liu, Haiyan
Huang, Hongming
Guo, Dan
FUTURE ONCOLOGY, 2020, 16 (16) : 1125 - 1136
[24] Gene Therapy With a High-Affinity Single-Chain p53-Specific TCR Mediates Potent Anti-Tumor Response Without Inducing Gvhd In Vivo
Echchannaoui, Hakim
Petschenka, Jutta
Antunes, Edite
Theobald, Matthias
BLOOD, 2013, 122 (21)
[25] NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease
Mastaglio, Sara
Genovese, Pietro
Magnani, Zulma
Ruggiero, Eliana
Landoni, Elisa
Camisa, Barbara
Schiroli, Giulia
Provasi, Elena
Lombardo, Angelo
Reik, Andreas
Cieri, Nicoletta
Rocchi, Martina
Oliveira, Giacomo
Escobar, Giulia
Casucci, Monica
Gentner, Bernhard
Spinelli, Antonello
Mondino, Anna
Bondanza, Attilio
Vago, Luca
Ponzoni, Maurilio
Ciceri, Fabio
Holmes, Michael C.
Naldini, Luigi
Bonini, Chiara
BLOOD, 2017, 130 (05) : 606 - 618
[26] TREATMENT OF MULTIPLE-MYELOMA WITH M-2 PROTOCOL AND WITHOUT MAINTENANCE THERAPY
PACCAGNELLA, A
CARTEI, G
FOSSER, V
SALVAGNO, L
BOLZONELLA, S
SILENI, VC
FIORENTINO, MV
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (10): : 1345 - 1351
[27] CRISPR-Based Gene-Editing Screens Revealed Modulators of Dexamethasone Sensitivity in Multiple Myeloma
Sobh, Amin
Bonilla, Emilie
Patel, Alisha
Li, Jianping
Dalal, Mansi
Riva, Alberto
Bennett, Richard Lynn
Licht, Jonathan D.
BLOOD, 2023, 142
[28] REARRANGEMENT (REARR) OF T-CELL RECEPTOR (TCR)-GAMMA CHAIN GENE IN MULTIPLE-MYELOMA (MM)
LEE, M
SELVANAYAGAM, P
ALEXANIAN, R
STASS, S
BARLOGIE, B
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 178 - 178
[29] A Clinically Usable Gene Expression Report for Risk Assessment and Identification of Possible Therapeutic Targets in Multiple Myeloma
Meibner, Tobias
Seckinger, Anja
Hielscher, Thomas
Reme, Thierry
Moreaux, Jerome
Benner, Axel
Bertsch, Uta
Jauch, Anna
Neben, Kai
Moehler, Thomas
Klein, Bernard
Goldschmidt, Hartmut
Hose, Dirk
BLOOD, 2009, 114 (22) : 726 - 727
[30] High-Risk Multiple Myeloma Patients Are Missed without Gene Expression Profiling
Van Vliet, Martin H.
Chen, Yan-Ting
Van Beers, Erik H.
Kuiper, Rowan
Valent, Erik T.
Spaan, Marieke
Terragna, Carolina
Zamagni, Elena
Cavo, Michele
Oliva, Stefania
Larocca, Alessandra
Haferlach, Torsten
Chng, Wee-Joo
Waage, Anders
Duin, M.
Sonneveld, Pieter
BLOOD, 2020, 136

← 1 2 3 4 5 →